GSK to Buy Food Allergy Drugmaker RAPT in 2.2bn Deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
GSK agreed to acquire US biotech RAPT for 2.2bn, gaining a promising food allergy drug that could become a blockbuster by 2031.
Back to articles

Actual Topics

Wed, 21 Jan 2026 03:30:05 GMT

Danish Pension Fund to Divest U.S. Treasuries Over Fiscal Concerns

Denmark's AkademikerPension will sell about 100 million in U.S. Treasuries by month-end, citing weak U.S. government finances, not politics.

Tue, 20 Jan 2026 18:30:03 GMT

Netflix Switches to All-Cash Bid for Warner Bros to Block Paramount

Netflix revised its Warner Bros deal to an all-cash offer at 27.75 per share, aiming to shut out Paramount and speed shareholder approval.

Subscribe to "Fundamental Analysis" feed

Souscrire
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.